Skip to main content

iShares Genomics Immunology and Healthcare ETF

Open-end / ETF
Registrant
iShares Trust
Class ticker
Net Assets
$190,862,668
Holdings
61
Latest Report
Jul 31, 2026

Net Assets Over Time

Holdings · 61

Export CSV

Securities-lending collateral: 1 row, $19,834,626 (10.39% of net assets). The report marks these as cash received from borrowers of the fund's securities and reinvested, not as positions the fund chose.

Showing 1–50 of 61 holdings by value · page 1 of 2
Holding Balance Value % of Fund Open
BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares
Lending collateral
19,834,626 $19,834,626 10.39%
Bayer Aktiengesellschaft
165,508 $9,184,987 4.81%
GENMAB A/S
28,069 $8,079,336 4.23%
Takeda Pharmaceutical Company Limited
225,100 $7,728,949 4.05%
Roche Holding AG
16,796 $7,341,404 3.85%
IPSEN SA
37,928 $7,328,654 3.84%
GSK PLC
266,670 $6,934,182 3.63%
SANOFI SA
76,788 $6,612,342 3.46%
ONO PHARMACEUTICAL CO., LTD.
244,500 $3,654,051 1.91%
Sunshine Lake Pharma Co Ltd
351,500 $1,874,392 0.98%
GenFleet Therapeutics (Shanghai) Inc
419,200 $1,480,868 0.78%
Shanghai Henlius Biotech Inc
135,900 $964,127 0.51%
VALNEVA SE
349,239 $866,333 0.45%
AbClon Inc.
34,319 $469,839 0.25%
BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares
177,863 $177,863 0.09%
JAPANESE YEN
11,386,897 $71,568 0.04%

Showing the top 50 of 61 holdings. Create a free account to see every holding and download the CSV.